GSK sees blockbuster potential in targeted cancer therapy after promising early data
GSK sees blockbuster potential in targeted cancer therapy after promising early data
Source link
Similar Posts
1 Magnificent TSX Stock Down 80% With Massive Growth Potential
A proven strategy to generate outsized gains is to invest in quality stocks trading at a discount to their intrinsic value. Canadian investors need to identify companies poised to grow revenue and earnings steadily while trading at a reasonable valuation. In this article, I have identified one magnificent TSX stock that is down 80% from…
RRSP Wealth: 2 TSX Dividend Stocks to Own for Decades
Canadian savers are searching for top TSX dividend stocks to add to their self-directed Registered Retirement Savings Plan (RRSP) portfolios. With the market near record levels, it makes sense to consider stocks with long histories of delivering dividend growth through full economic cycles. Fortis Fortis (TSX:FTS) is a Canadian utility company with operations in Canada,…
DCB Bank Shares Skyrocketed 9% on Strong Q2 Earnings – Equitypandit
October 25, 2024October 25, 2024 Shares of DCB Bank Ltd skyrocketed 9% on 25 September after the company announced its quarterly earnings for the July-September quarter. The bank reported a 23% year-on-year (YoY) increase in net profit to Rs 155 crore for the quarter under…
BLS: Job Openings Unchanged at 7.2 million in August
by Calculated Risk on 9/30/2025 10:00:00 AM From the BLS: Job Openings and Labor Turnover Summary The number of job openings was unchanged at 7.2 million in August, the U.S. Bureau of Labor Statistics reported today. Over the month, both hires and total separations were little changed at 5.1 million. Within separations, both quits (3.1…
